Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interventions Against Insulin Resistance in Pulmonary Arterial Hypertension
NCT03617458Phase 2Completed
- Sponsor
- Vanderbilt University Medical Center
- Start
- Aug 2018
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of liquid metformin (Aspargo Labs) in pulmonary arterial hypertension (PAH), sponsored by Vanderbilt University Medical Center. Started Aug 2018; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT03617458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03617458.